Literature DB >> 10798213

Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.

I R Rowland1, H Wiseman, T A Sanders, H Adlercreutz, E A Bowey.   

Abstract

The soy isoflavones, daidzein and genistein, and the lignans, matairesinol and secoisolariciresinol, are phytoestrogens metabolized extensively by the intestinal microflora. Considerable important evidence is already available that shows extensive interindividual variation in isoflavone metabolism, and we have investigated the extent of this variation in a crossover study of a soy-containing food low or high in isoflavones (each treatment period lasted for 17 days, and the 2 treatment periods were separated by a 25-day washout period) in 24 healthy subjects [19 women and 5 men, mean age 30 yr, range 19-40, mean body mass index 22.5 +/- 3.5 (SD) kg/m2]. There was a 16-fold variation in total isoflavonoid excretion in urine after the high-isoflavone treatment period. The variation in urinary equol excretion was greatest (664-fold), and subjects fell into two groups: poor equol excretors and good equol excretors (36%). A significant negative correlation was found between the proportion of energy from fat in the habitual diet and urinary equol excretion (r = -0.55; p = 0.012). Good equol excretors consumed less fat as percentage of energy than poor excretors (26 +/- 2.3% compared with 35 +/- 1.6%, p < 0.01) and more carbohydrate as percentage of energy than poor excretors (55 +/- 2.9% compared with 47 +/- 1.7%, p < 0.05). Interindividual variation in the urinary excretion of O-desmethyl-angolensin (O-DMA) was also apparent (76-fold after the high-isoflavone treatment period), but there was no relationship between equol excretion and O-DMA excretion. Enterolactone was the major lignan metabolite in urine and plasma but showed less interindividual variation than equol and O-DMA. It is suggested that the dietary fat intake decreases the capacity of gut microbial flora to synthesize equol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798213     DOI: 10.1207/S15327914NC3601_5

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  103 in total

1.  Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Authors:  Emily J Tomayko; Hae R Chung; Kenneth R Wilund
Journal:  J Bone Miner Metab       Date:  2011-06-03       Impact factor: 2.626

2.  Cautions and research needs identified at the equol, soy, and menopause research leadership conference.

Authors:  Stephen Barnes; Helen Kim
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 3.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

4.  Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.

Authors:  Jennifer H Ahn-Jarvis; Steven K Clinton; Elizabeth M Grainger; Kenneth M Riedl; Steven J Schwartz; Mei-Ling T Lee; Raul Cruz-Cano; Gregory S Young; Gregory B Lesinski; Yael Vodovotz
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

5.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

6.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

Review 7.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-08

8.  Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans.

Authors:  Thomas Clavel; Gemma Henderson; Carl-Alfred Alpert; Catherine Philippe; Lionel Rigottier-Gois; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

9.  S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Authors:  Mandeep K Virk-Baker; Stephen Barnes; Helen Krontiras; Tim R Nagy
Journal:  Nutr Res       Date:  2013-12-18       Impact factor: 3.315

Review 10.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.